Industry News
Stay up to date with the latest news in the pharmaceutical industry
LATEST NEWS
Novartis has moved to seal an exclusive licence agreement with Swiss group Debiopharm for the development, manufacture and commercialisation of Debio 025 (alisporivir), which has shown a potent effect on the hepatitis C virus (HCV).
09 February 2010
Vantia’s Nocturia Candidate Enters Stage Two Trials
09 February 2010
09 February 2010
Addex Pain Drug Shows Broad Effects
09 February 2010
09 February 2010
FDA Approves Hypertension Generics
09 February 2010
09 February 2010
Teva to Settle Drug Price Fixing Claims
08 February 2010
08 February 2010
SWIFT Haemophilia Drug Trials Begin
08 February 2010
08 February 2010
Novavax Stops Flu Vaccine Collaboration
08 February 2010
08 February 2010
BioMarin to Acquire LEAD Therapeutics
08 February 2010
08 February 2010
GSK Launches Special Disease Unit
05 February 2010
05 February 2010
Qiagen and Pfizer to Develop Brain Tumour Diagnostic
05 February 2010
05 February 2010
Shire Applies For Fabry Drug Licensing in US
05 February 2010
05 February 2010
Avexa Announces Positive HIV Therapy Trials
05 February 2010
05 February 2010
Ipsen and Debiopharm Launch New Cancer Drug in France
04 February 2010
04 February 2010
Teva Files Application for New Neutropenia Drug
04 February 2010
04 February 2010
